Skip to main content
Clinical Trials/ACTRN12620000243910
ACTRN12620000243910
Recruiting
未知

Is skeletal muscle microvascular dysfunction a key determinant of exercise intolerance and impaired glycaemic control in patients with type 2 diabetes?

Deakin University0 sites56 target enrollmentFebruary 26, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Metabolic and endocrine
Sponsor
Deakin University
Enrollment
56
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Aged 40–80 years.
  • 2\.Clinical diagnosis of pre\-diabetes (HbA1C \= 5\.7%) or T2D (HbA1C \= 6\.5%)
  • Controlled diabetes through diet or medication (excluding insulin) for at least 8 weeks.
  • 3\.Have given signed informed consent to participate in the study.

Exclusion Criteria

  • 1\.Age \<40 years or \> 80 years.
  • 2\.Patients using insulin to control blood sugar levels.
  • 3\.Pulmonary hypertension.
  • 4\.Atrial fibrillation.
  • 5\.Cardiovascular disease including coronary artery disease or heart valve disease.
  • 6\.Poor ejection fraction (\<50%) or elevated left ventricle filling pressure (E/e’ \>15\).
  • 7\.Critical limb ischemia including peripheral artery disease or previous revascularisation or other surgical treatment for peripheral artery disease.
  • 8\.History of malignancy within past 5 years (except for non\-melanoma skin cancers).
  • 9\.Identification of any medical condition requiring immediate therapeutic intervention.
  • 10\.Uncontrolled hypertension (resting brachial blood pressure greater than or equal to 160/100 mmHg).

Outcomes

Primary Outcomes

Not specified

Similar Trials